Ladenburg Thalmann Downgrades Sequenom (SQNM) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Tech selloff weighs down Wall Street as bond yields climb
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Goldman Sachs to acquire real estate company LCN for up to $410M
- BofA raises hyperscaler AI capex outlook to $3.6tn through 2028
Jefferies Downgrades Sequenom (SQNM) to Hold
September 30, 2015 7:32 AM EDTJefferies downgraded Sequenom (NASDAQ: SQNM) from Buy to Hold with a price target of $1.50 (from $5.00).
Analyst Brandon Couillard commented, "Our prior Buy rating had been predicated on: 1) visibility to positive cash flow; and, 2) low valuation relative to other NIPT targets. However, after... More
William Blair Downgrades Sequenom (SQNM) to Market Perform
September 29, 2015 7:02 AM EDTWilliam Blair downgraded Sequenom (NASDAQ: SQNM) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Sequenom click here. For more ratings news on Sequenom click here.
Shares of Sequenom closed at $1.92 yesterday.
... MoreSequenom (SQNM) Lowers 2nd-Half Revenue Outlook
September 25, 2015 7:06 AM EDTSequenom (NASDAQ: SQNM) is updating its revenue expectations for the second half of the year to a range between $57 million and $61 million, bringing 2015 annual revenue expectations to a range between $127 million and $131 million. This versus the consensus of $141 million.
Drivers for the updated expectations include increased competition and price... More
Sequenom (SQNM) Guides FY Revenue Below Street Views
September 25, 2015 7:05 AM EDTSequenom, Inc. (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, provides its current revenue outlook for the second half of 2015.
The Company is updating its revenue expectations for the second half of the year to a range between $57 million and $61 million, bringing 2015 annual revenue... More
